# MAGNAM Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care

> **NCT05287191** · PHASE3 · UNKNOWN · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 200 (estimated)

## Conditions studied

- Atrial Fibrillation New Onset

## Interventions

- **DRUG:** Magnesium sulfate and then Digoxin
- **DRUG:** Amiodarone

## Key facts

- **NCT ID:** NCT05287191
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-05
- **Primary completion:** 2025-10-31
- **Final completion:** 2026-04-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05287191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05287191, "MAGNAM Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05287191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*